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Abstract: Spontaneous bacterial peritonitis (SBP) in patients with
cirrhosis is typically caused by gram-negative bacteria. However, the
number of SBP cases due to gram-positive bacteria is steadily increas-
ing. To date, little is known about the predictive factors involved in SBP
infections.
We performed a retrospective cohort study of patients (>18 years)
with SBP due to gram-positive and -negative bacteria whowere enrolled
from January 2006 to December 2013 at Severance Hospital in Seoul,
Korea where the incidences of hepatitis B virus associated chronic liver
disease, cirrhosis, and hepatocellular carcinoma are high. Only the 1st
SBP episode for each patient within the study period was included in our
analysis.
We identified 77 patients with cirrhosis and SBP. Of these, 27
patients (35%) had gram-positive bacterial infections and 50 patients
(65%) had gram-negative bacterial infections. Our univariate analysis
revealed that an early stage of cirrhosis (P¼ 0.004), lower creatinine
level (P¼ 0.011), lower Sequential Organ Failure Assessment (SOFA)
score (P¼ 0.001), lower Model for End-Stage Liver Disease score
(P¼ 0.005), and use of systemic antibiotics within 30 days before
SBP diagnosis (P¼ 0.03) were significantly associated with gram-
positive bacterial infections. Our multivariate analysis indicated that
the use of systemic antibiotics within 30 days before SBP diagnosis
(odds ratio, 3.94; 95% CI, 1.11–13.96; P¼ 0.033) and a lower SOFA
score (odds ratio, 0.56; 95% CI, 0.37–0.86; P¼ 0.007) were indepen-
dent predictive factors of SBP caused by gram-positive bacterial
infections in patients with cirrhosis. However, we did not observe a
statistically significant difference in the 28-day mortality between the
gram-positive and -negative bacterial infection groups (40.7% vs
46.0%, respectively; P¼ 0.407).
In this study, the incidence rate of SBP caused by gram-positive
bacteria in patients with cirrhosis was similar to the rates reported in
recently published studies. Furthermore, the use of systemic antibioticsoi, Sang Hoon Ah Song,
d June Myung Kim
(Medicine 95(17):e3489)
Abbreviations: CKD = chronic kidney disease, HCC =
hepatocellular carcinoma, PMN = polymorphonuclear leukocyte,
SBP = spontaneous bacterial peritonitis, SOFA = Sequential Organ
Failure Assessment.
INTRODUCTION
S pontaneous bacterial peritonitis (SBP) is one of the mostfrequent bacterial infections in patients with cirrhosis and
ascites, occurring in 10% to 25% of these patients.1 In addition,
SBP is associated with high mortality rates (20%–40%) in these
patients.2–4 SBP in patients with cirrhosis is typically caused by
gram-negative bacteria that are part of the intestinal microbial
flora (mainly species in the family Enterobacteriaceae).5–7
Thus, 3rd-generation cephalosporins are the initial empirical
therapy for SBP according to current guidelines.8,9 However, in
recent years there has been an increase in invasive procedures,
antibiotic prophylaxis, and widespread antibiotic use in patients
with cirrhosis, which has changed the bacterial spectrum and
lead to an increase in SBP by gram-positive bacteria.10–13
As a result of the recent changes in the epidemiology of
bacteria that cause SBP, the choice of antibiotics for SBP has
become a topic of discussion. It is thus important to understand
the predictive factors for SBP caused by gram-positive bacteria
in patients with cirrhosis. However, to our knowledge, no
published studies have focused on this topic.
We performed the present retrospective cohort study to
identify the predictive factors for and outcomes of SBP due to
gram-positive versus -negative bacterial infections.
MATERIALS AND METHODS
Study Design and Population
A retrospective cohort study was conducted to investigate
the predictive factors for SBP caused by gram-positive bacteria
in patients with cirrhosis. We enrolled 77 patients with cirrhosis
and SBP (>18 years) who were hospitalized at the Severance
Hospital in Seoul, Korea from 1 January 2006 to 31 December
2013. We only included the 1st episode of SBP for each patient
within the study period in our analysis. Patients with a positive
culture for highly suspicious skin contaminants (i.e., coagulase-
negative Staphylococci, Corynebacterium, Propionibacterium,
or Bacillus spp) and those with secondary peritonitis were
excluded from this study. Secondary peritonitis was considered
in patients with the following cases: polymicrobial infection,
peritoneal dialysis, indwelling abdominal catheters, and a recentrgery. We reviewed the medical records
cted the following information: age, sex,
dPugh score, concomitant hepatocellular
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carcinoma (HCC), history of undergoing transcatheter arterial
chemoembolization, initial presenting symptoms, type of iso-
lated bacteria, gastrointestinal bleeding, presentation of septic
shock, laboratory results, history of SBP, and use of systemic
antibiotics within 30 days before SBP diagnosis.
The study was approved by the Institutional Review Board
(IRB) of Yonsei University Health System Clinical Trial Center.
Since the study was retrospective and the study subjects were
anonymized, the IRB waived the requirement for written con-
sent from the patients.
Definitions
SBP was defined by the presence of ascitic fluid with a
polymorphonuclear leukocyte (PMN) count of>250 cells/mm3,
and culture-positive SBP implied a positive culture result in
ascitic fluid among SBP. During the study period, 204 patients
with cirrhosis and SBP were observed, including 127 culture-
negative SBP cases. Cirrhosis in all patients was confirmed by
clinical, hematological, and biochemical laboratory findings
and ultrasound. Chronic kidney disease (CKD) was defined as a
glomerular filtration rate of <60mL/min/1.73m2 for 3
months irrespective of other signs of kidney damage.14 Noso-
comial infection was defined as an infection that occurred
>48 hours after admission to the hospital. Infections diagnosed
within the 1st 48 hours of hospitalization were classified as
community-acquired infections.12 Hepatic encephalopathy was
defined as an episode of mental confusion, disorientation,
excitation, abnormal behavior, or asterixis.15 Gastrointestinal
variceal bleeding was confirmed by endoscopy.16 Antibiotic
prophylaxis therapy was defined as the use of rifaximin (Nor-
mix).17 Septic shock was defined as sepsis associated with
evidence of organ hypoperfusion and a systolic blood pressure
of<90mmHg,>30mmHg less than baseline, or a requirement
for the use of a vasopressor to maintain blood pressure.2 Clinical
manifestations included the presence of the following initial
symptoms: fever (temperature of >38 8C), abdominal pain, and
diarrhea (defined as >3 loose stools per day).
Laboratory Tests
Ascitic fluid specimens were obtained aseptically by para-
centesis and inoculated into blood culture bottles at the bedside.
Ascitic fluid samples were also sent to the microbiology
laboratory for PMN counting and Gram staining. We injected
10mL of ascitic fluid samples into blood bottles (bioMerieux)
and cultured using BacT/ALERT 3D system (bioMerieux).
Remaining ascitic fluid from each sample was cultured using
conventional methods (i.e., MacConkey agar, inoculating blood
agar, thioglycollate broth, and phenylethanol agar). After day 3
of incubation and a lack of growth, conventional agar was
considered negative and discarded.
Statistical Analysis
Independent t tests were used to compare continuous
variables, and Chi-square or Fisher exact tests were used to
compare categorical variables. Predictive factors for gram-
positive bacterial infections were determined by a multivariate
binary logistic regression analysis including significant uni-
variate predictors (P< 0.05) using a stepwise backward elim-
ination from the total cohort of culture-positive cases of SBP. P-
Kim et alvalues of<0.05 were considered statistically significant. PASW
ver. 18 for Windows (SPSS Inc., Chicago, IL) was used
for analyses.
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Demographic Characteristics
In total, 77 patients with cirrhosis and SBP were identified
(61 male and 16 female). Table 1 shows the demographic and
clinical characteristics of the patients. The most frequent causes
of cirrhosis were hepatitis B virus (55.8%), hepatitis C virus
(20.8%), and excessive alcohol ingestion (14.3%). There were 3
patients (3.9%) in Child–Pugh class A, 23 patients (29.9%) in
class B, and 51 (66.2%) in class C.
Microbiological Characteristics
The organisms isolated from the ascitic fluid of patients
with SBP are listed in Table 2. There were 50 patients (64.9%)
with gram-negative infections and 27 patients (35.1%) with
gram-positive infections. Escherichia coli was the most com-
mon isolate (32.5%), followed by Klebsiella pneumoniae
(19.5%). Eleven of the gram-negative bacteria (22%) were
extended spectrum beta-lactamase (ESBL) positive (þ). For
patients with gram-positive bacterial infections, Enterococcus
spp and Staphylococcus aureus were the most common isolates
(13.0%), followed by Streptococcus spp (9.1%). Enterococci
species included 7 Enterococcus faecium, 2 E raffinosus, and 1
E faecalis. Two of the E faecium isolates were vancomycin
resistant. Staphylococcus aureus comprised 6 methicillin-resist-
ant S aureus (MRSA) and 4 methicillin-susceptible S aureus
(MSSA). Antibiotics used for the definitive treatment of SBP
were listed in Table 3. We did not observe a statistically
significant difference in the proportion of patients who received
appropriate definitive antimicrobial therapy considering their
susceptibility testing results between the gram-positive and -
negative bacterial infection groups (84.6% vs 92%, respect-
ively; P¼ 0.264).
Predictive Factors of Gram-Positive Bacterial
Infections
There were no statistically significant differences in age,
sex, cause of cirrhosis, concomitant HCC, history of undergoing
transcatheter arterial chemoembolization, underlying diabetes
mellitus, CKD, or history of SBP between patients with gram-
positive and -negative bacterial infections.
However, the results of our univariate analysis indicated
that the following factors were significantly associated with
gram-positive bacterial infections: early stage of cirrhosis
(P¼ 0.004), a low creatinine level (P¼ 0.011), a low Sequential
Organ Failure Assessment (SOFA) score (P¼ 0.001), a low
Model for End-Stage Liver Disease score (P¼ 0.005), and use
of systemic antibiotics within 30 days before SBP diagnosis
(P¼ 0.03). The results of the multivariate analysis revealed that
the use of systemic antibiotics within 30 days before SBP
diagnosis (odds ratio, 3.94; 95% confidence interval, 1.11–
13.96; P¼ 0.033) and a lower SOFA score (odds ratio, 0.56;
95% confidence interval, 0.37–0.86; P¼ 0.007) were indepen-
dent predictive factors for SBP caused by gram-positive bac-
terial infections in patients with cirrhosis. However, we did not
observe a statistically significant difference in 28-day mortality
between the gram-positive and -negative bacterial infection
groups (40.7% vs 46.0%, respectively; P¼ 0.407) (Table 4).
Medicine  Volume 95, Number 17, April 2016DISCUSSION
SBP is a common complication in patients with cirrhosis
and ascites despite recent improvements in therapeutic
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TABLE 1. Clinical Characteristics and Laboratory Findings of Patients With Spontaneous Bacterial Peritonitis
Total (n¼ 77) Gram (þ) Infection (n¼ 27) Gram () Infection (n¼ 50) P-Value
Age 58.6 10.2 59.5 9.4 58.1 10.7 0.565
Sex 0.430
Male 61 (79.2) 21 (77.8) 40 (80)
Female 16 (20.8) 6 (22.2) 10 (20)
Cause of liver cirrhosis 0.424
HBV 43 (55.8) 15 (55.6) 28 (56)
HCV 16 (20.8) 8 (29.6) 8 (16)
Alcohol 11 (14.3) 2 (7.4) 9 (18)
NBNC 7 (9.1) 2 (7.4) 5 (10)
Child–Pugh classification 0.004
A 3 (3.9) 3 (11.1) 0
B 23 (29.9) 11 (40.7) 12 (24)
C 51 (66.2) 13 (48.2) 38 (76)
MELD score 20.87 6.57 18.07 7.01 22.38 5.86 0.005
HCC 43 (55.8) 15 (55.6) 28 (56) 0.686
TACE history 35 (45.5) 13 (48.2) 22 (44) 0.963
DM 21 (27.3) 7 (25.9) 14 (28) 0.890
Type of DM therapy
Insulin 5 (6.49) 2 (7.4) 3 (6) 0.758
Oral hypoglycemic agent 12 (15.58) 3 (11.1) 9 (18) 0.561
CKD 14 (18.2) 4 (14.8) 10 (20) 0.761
Ulcer disease 32 (41.6) 12 (44.4) 20 (40) 0.654
Malignant solid organ tumor 50 (64.9) 20 (74.1) 30 (60) 0.253
Malignant lymphoma 2 (2.6) 2 (7.4) 0 0.117
Previous variceal bleeding 38 (49.4) 11 (40.7) 27 (54) 0.317
Previous HEP 28 (36.4) 8 (29.6) 20 (40) 0.409
SBP history 6 (7.8) 1 (3.7) 5 (10) 0.659
Rifaximin within 30 days before
SBP diagnosis
11 (14.3) 4 (14.8) 7 (14) 1
Use of systemic antibiotics within
30 days before SBP diagnosis
27 (35.1) 14 (51.9) 13 (26) 0.03
Nosocomial infection (>48 hours) 33 (42.9) 15 (55.6) 18 (36) 0.16
Combined UTI 8 (10.39) 1 (3.7) 7 (14) 0.248
Mucositis 1 (1.3) 0 (0.0) 1 (2) 1
PPI administration 22 (28.6) 9 (33.3) 13 (26) 0.497
Soft tissue infection 0 (0.0) 0 (0.0) 0 (0) 1
Steroid use 2 (2.6) 1 (3.7) 1 (2) 1
NSBB use 22 (28.6) 4 (14.8) 18 (36) 0.065
BMI 22.28 2.8 22.52 3.08 22.16 2.67 0.614
Bacteremia 32 (41.6) 7 (25.9) 25 (50) 0.052
Septic shock 17 (22.1) 3 (11.1) 14 (28) 0.148
Appropriate definitive
antimicrobial therapy
68 (89.5) 22 (84.6) 46 (92) 0.264
SOFA score 6.1 2.26 4.74 1.91 6.84 2.1 0.001
Charlson index 6.47 2.77 6.81 2.68 6.28 2.83 0.409
28-day mortality 34 (44.2) 11 (40.7) 23 (46) 0.407
Serum
WBC count, /mm3 9250 5797 9090 4052 9337 6587 0.840
Platelet, 109/L 94 50 108 65 86 38 0.131
Creatinine, mg/dL 2.02 1.83 1.43 0.93 2.34 2.1 0.011
Albumin, g/dL 2.45 0.42 2.55 0.42 2.39 0.42 0.114
Total bilirubin, mg/dL 5.64 5.87 6.03 7.87 5.43 4.52 0.721
Prothrombin time (INR) 1.60 0.55 1.48 0.53 1.66 0.55 0.155
CRP, mg/dL 72.79 50.34 66.83 43.06 76 54 0.449
HbA1c 6.87 1.46 6.68 1.1 6.93 1.59 0.77
Peritoneal fluid
WBC, /mm3 6140 6973 4487 5023 7033 7727 0.127
PMN count, /mm3 5201 6490 3538 4769 6099 7136 0.099
Protein, g/dL 1.28 0.7 1.38 0.85 1.23 0.61 0.384
Albumin, g/dL 0.6 0.31 0.68 0.4 0.56 0.24 0.183
Data are number (%) of patients, unless otherwise indicated. BMI¼ body mass index, CKD¼ chronic kidney disease, CRP¼C-reactive protein,
DM¼ diabetes mellitus, HBV¼ hepatitis B virus, HCC¼ hepatocellular carcinoma, HCV¼ hepatitis C virus, HEP¼ hepatic encephalopathy,
MELD¼Model for End-Stage Liver Disease, NBNC¼ non-hepatitis B non-hepatitis C, NSBB¼ nonselective b-blocker, PMN¼ polymorphonuclear
leukocyte, PPI¼ proton pump inhibitor, SBP¼ spontaneous bacterial peritonitis, SOFA¼ sequential organ failure assessment, TACE¼ transcatheter
arterial chemoembolization, UTI¼ urinary tract infection, WBC¼white blood cell.
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TABLE 2. Bacteria Isolated From Ascitic Fluid in Patients With Spontaneous Bacterial Peritonitis
Microorganisms Susceptibility n¼ 77
Gram-positive (n¼ 27, 35.1%) Enterococcus spp VSE 8 (10.39)
VRE 2 (2.60)
Staphylococcus aureus MSSA 4 (5.19)
MRSA 6 (7.79)
Streptococcus spp 7 (9.09)
Aeromonas spp ESBL (–) 3 (3.90)
ESBL (þ) 1 (1.30)
Citrobacter freundii ESBL (–) 2 (2.60)
ESBL (þ) 0
Enterobacter spp ESBL (–) 2 (2.60)
ESBL (þ) 0
Gram-negative (n¼ 50, 64.9%) Escherichia coli ESBL (–) 21 (27.27)
ESBL (þ) 4 (5.19)
Klebsiella pneumoniae ESBL (–) 9 (11.69)
ESBL (þ) 6 (7.79)
Providencia rettgeri ESBL (–) 1 (1.30)
ESBL (þ) 0
Pseudomonas aeruginosa ESBL (–) 1 (1.30)
ESBL (þ) 0
Data are the numbers (%) of patients. ESBL¼ extended spectrum beta-lactamase, MRSA¼methicillin-resistant S. aureus, MSSA¼methicillin-
va
Kim et al Medicine  Volume 95, Number 17, April 2016approaches.1 Gram-negative bacteria (most frequently E coli)
through translocation from the intestinal lumen are responsible
for the majority of SBP cases.6 However, the preponderance of
infections caused by gram-negative bacteria due to epidemio-
logical changes has shifted to a higher prevalence of infections
being caused by gram-positive cocci.18 In a study by Alexo-
poulou et al,13 the majority of isolated pathogens from patients
with SBP were gram-positive cocci (55%). Our findings are in
agreement with several recent reports that showed a high
frequency of gram-positive bacterial infections associated with
susceptible S. Aureus, VRE¼ vancomycin-resistant Enterococci, VSE¼SBP.11,13,19
We observed that the use of systemic antibiotics within 30
days before SBP diagnosis and a lower SOFA score were
TABLE 3. Antibiotics Used for the Definitive Treatment of Sponta
Microorganisms Quinolones Cephalos
Gram-positive
(n¼ 27, 35.1%)
Enterococcus spp 2 (0
Staphylococcus aureus 3 (2
Streptococcus spp 1 (1) 6 (6
Aeromonas spp 2 (2) 2 (2
Citrobacter freundii 2 (2
Enterobacter spp 2 (2
Gram-negative
(n¼ 50, 64.9%)
Escherichia coli 17 (1
Klebsiella pneumoniae 1 (1) 6 (5
Providencia rettgeri
Pseudomonas aeruginosa
Total n 4 (4) 40 (3
Data are the numbers of patients. Figures in parenthesis refer to the nu
susceptibility testing results.
4 | www.md-journal.comindependent predictors of SBP caused by gram-positive bacteria
in patients with cirrhosis. However, the effects of proton pump
inhibitor administration, taking nonselective b-blocker and
taking rifaximin for prophylaxis within 30 days before SBP
diagnosis on the predominance of gram-positive bacteria could
not be proven in our study.
In this study, the use of systemic antibiotics within 30 days
before SBP diagnosis was an independent predictive factor in
patients with cirrhosis and SBP caused by gram-positive bac-
terial infections. Innate and adaptive immune dysfunction, also
ncomycin-susceptible Enterococci.referred to as cirrhosis-associated immune dysfunction syn-
drome, is a major component of cirrhosis.20 Bacterial infections
are common and represent important causes of liver-related
neous Bacterial Peritonitis (SBP)
porins
Piperacillin/
Tazobactam Carbapenem Glycopeptide Tigecycline
) 2 (2) 5 (5)
) 1 (0) 5 (5) 1 (1)
)
)
)
)
4) 3 (3) 5 (5)
) 8 (8)
1 (1)
1 (1)
3) 6 (6) 15 (14) 10 (10) 1 (1)
mbers of patients who treated with appropriate antibiotics considering
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.
TABLE 4. Predictive Factors for Gram-Positive Bacterial Infection in Patients With Spontaneous Bacterial Peritonitis
Multivariate Analysis
OR (95% CI) P-Value
Antimicrobial therapy within the past 30 days 3.943 (1.114–13.96) 0.033
SOFA score 0.562 (0.368–0.857) 0.007
Creatinine level 0.887 (0.525–1.499) 0.654
Child–Pugh classification 0.971
MELD score 1.009 (0.879–1.158) 0.898
se,
Medicine  Volume 95, Number 17, April 2016 A Retrospective Cohort Studycomplications, progression of liver failure, and mortality related
to cirrhosis.21 In actual fact, bacterial infections may trigger the
development of gastrointestinal bleeding, hepatic encephalo-
pathy, hypervolemic hyponatremia, kidney disease, and acute-
on-chronic liver failure.21,22 Thus, early diagnosis and prompt
initiation of adequate antibiotic therapy is essential in the
management of patients with cirrhosis and bacterial infec-
tions.23 As a result, patients with cirrhosis consume more
antibiotics than the general population. In our study, 27 patients
(35.1%) had taken systemic antimicrobial therapy within the
past 30 days, but in cases of gram-positive bacterial infections,
the proportion increased to 51.9% (14 of 27). This result might
be attributed to 2 factors. First, although there were no statisti-
cally significant differences between the 2 groups in the rate of
nosocomial infections, gram-positive bacterial infections were
reported more frequently in the hospital than gram-negative
infections (55.6% vs 36.0%, respectively; P¼ 0.16). Second,
the prevalence of infections caused by multiresistant bacteria
(e.g., methicillin-resistant S aureus and E faecium) is increasing
in cirrhosis patients.19
In addition, this study showed that a lower SOFA score was
associated with SBP caused by gram-positive bacterial infec-
tions in patients with cirrhosis. The SOFA score is a simple but
effective method to describe organ dysfunction/failure in cri-
tically ill patients not only in the ICU but also in other places,
such as emergency departments.24,25 As many patients with
SBP were admitted via the emergency department, calculating
the SOFA score is important for predicting the outcome along
with other clinical information. Regular, repeated scoring
enables a patient’s condition and disease development to be
monitored and better understood.26 In our study, gram-negative
bacterial infections were associated with a higher SOFA score
than gram-positive infections (6.84 vs 4.74, respectively;
P¼ 0.005). This result is likely attributed to the higher inci-
dence of gram-negative bacterial infections in advanced cir-
rhosis. According to the most widely accepted theory, the initial
event of SBP is translocation of intestinal bacteria to the
mesenteric lymph nodes and subsequently into the systemic
circulation. In patients with impaired reticuloendothelial pha-
gocytic activity, this process becomes clinically relevant and
leads to spontaneous bacteremia. When defense mechanisms
within ascitic fluid are reduced, the circulating organisms
colonize the peritoneal fluid, leading to SBP.10 Thus, one of
the steps in SBP was a disturbance in gut flora caused by
commonly overgrowing gram-negative aerobic bacteria, such
CI¼ confidence interval, MELD¼Model for End-Stage Liver Diseaas E coli. Bacteria within the gut lumen can traverse the
intestinal wall, colonize mesenteric lymph nodes, move into
the systemic circulation, and enter the ascitic fluid through the
Copyright # 2016 Wolters Kluwer Health, Inc. All rights reserved.liver.13 As a result, if cirrhosis progresses, the chance of
obtaining SBP by gram-negative bacteria increases. This could
be one of the reasons why gram-negative bacterial infections
were associated with a higher SOFA score in the present study.
This study had several limitations that should be addressed.
First, the patients included in this study were from a single center
in theRepublic ofKorea,where the incidence of hepatitis B virus-
associated CKD, cirrhosis, and HCC are high. Therefore, the
results might not be applicable to different hospitals. Second,
there is potential for bias and inaccurate data collection because it
was a retrospective study. Further prospective studies conducted
in larger patient populations involving multiple centers will be
necessary. Third, this study did not include patientswith bacterial
ascites (defined as a positive culture result in ascitic fluid without
an elevated PMN count). In clinical practice, patients with this
condition are occasionally treated with antibiotics. However, in
this study, we just included patients with culture-positive SBP;
thus, selection bias might have occurred.
CONCLUSIONS
In conclusion, our findings are in agreement with several
recent studies that reported a high frequency of gram-positive
SBP.11,13,19 In addition, the use of systemic antibiotics within 30
days before SBP diagnosis and a lower SOFA score were
significantly associated with SBP caused by gram-positive
bacteria in patients with cirrhosis. Therefore, it is important
that physicians take all of these factors into account when
diagnosing and treating patients with cirrhosis and SBP.
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